HK33995A - Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure - Google Patents

Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure

Info

Publication number
HK33995A
HK33995A HK33995A HK33995A HK33995A HK 33995 A HK33995 A HK 33995A HK 33995 A HK33995 A HK 33995A HK 33995 A HK33995 A HK 33995A HK 33995 A HK33995 A HK 33995A
Authority
HK
Hong Kong
Prior art keywords
oxo
treatment
heart failure
prophylaxis
alkyl group
Prior art date
Application number
HK33995A
Other languages
English (en)
Inventor
Masami Kubo
Takashi Ochiai
Hirofumi Yuasa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of HK33995A publication Critical patent/HK33995A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK33995A 1986-12-09 1995-03-09 Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure HK33995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29457486 1986-12-09

Publications (1)

Publication Number Publication Date
HK33995A true HK33995A (en) 1995-03-17

Family

ID=17809540

Family Applications (1)

Application Number Title Priority Date Filing Date
HK33995A HK33995A (en) 1986-12-09 1995-03-09 Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure

Country Status (9)

Country Link
US (1) US4888339A (da)
EP (1) EP0274230B1 (da)
KR (1) KR930004646B1 (da)
AT (1) ATE81466T1 (da)
CA (1) CA1296638C (da)
DE (1) DE3782235T2 (da)
DK (1) DK165967C (da)
HK (1) HK33995A (da)
SG (1) SG4595G (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344403A (en) * 1993-06-09 1994-09-06 Rahnfong Lee Simple retractable safety syringe
DE202020102656U1 (de) 2020-05-12 2020-06-04 Sys-Pro Gmbh RFID-Lesetunnel zur Identifizierung von Objekten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
PH19153A (en) * 1981-11-04 1986-01-15 Merrell Dow Pharma Treatment of cardiac failure using imidazolecarboxylic acid derivatives
JPS6058233B2 (ja) * 1982-05-24 1985-12-19 田辺製薬株式会社 ２−オキソイミダゾリジン誘導体及びその製法
JPS61158968A (ja) * 1984-12-29 1986-07-18 Daicel Chem Ind Ltd フエナシル誘導体
JPH0613715A (ja) * 1992-06-26 1994-01-21 Rohm Co Ltd 端面発光素子およびその製法

Also Published As

Publication number Publication date
SG4595G (en) 1995-06-16
DE3782235D1 (de) 1992-11-19
DK644487D0 (da) 1987-12-08
EP0274230A2 (en) 1988-07-13
ATE81466T1 (de) 1992-10-15
KR890009886A (ko) 1989-08-04
DK165967B (da) 1993-02-22
KR930004646B1 (ko) 1993-06-02
DK644487A (da) 1988-06-10
DE3782235T2 (de) 1993-02-25
CA1296638C (en) 1992-03-03
US4888339A (en) 1989-12-19
EP0274230A3 (en) 1990-05-16
EP0274230B1 (en) 1992-10-14
DK165967C (da) 1993-07-26

Similar Documents

Publication Publication Date Title
EP0430045A3 (en) Ascorbic acid tocopheryl phosphate diesters for inhibition of maillard's reaction
GR3018086T3 (en) Heterocyclic bisphosphonic acid derivatives.
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
GR3005990T3 (da)
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
DE69001722D1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
GR3007401T3 (da)
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
ZA928876B (en) Thiazole derivatives.
SG4595G (en) Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure
GR3007219T3 (da)
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
EP0301466A3 (en) Uricosuric composition
EP0323604A3 (en) A venous extensibility improving and cardiac hypertrophy suppressant agent containing a dihydropyridine compound
ZA912589B (en) A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
EP0447812A3 (en) Use of a dihydropyridine to improve the inner ear blood circulation

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20071207